ICR and Cancer Research UK spinout company Monte Rosa Therapeutics launches with library of anti-cancer compounds 10 Jun 2020 A company formed as a spinout from Cancer Research UK-funded science at The Institute of Cancer Research, London, has been publicly launched – revealing $32.5m in funding and a library of innovative anti-cancer compounds. Find out more Show/Hide